A federal judge issued a preliminary injunction against a new government pilot set to significantly shift how certain ...
The Trump administration made work requirements for low-income people receiving government assistance a priority in 2025.
In Washington, D.C., lawmakers are engaged in marathon talks about how to reduce health care costs. There haven’t been any ...
A federal judge has allowed South Dakota’s new 340B drug‑discount law to remain in effect while a legal challenge from pharmaceutical giant AbbVie moves forward.
As we look ahead to 2026, the operational demands on 340B programs are increasing across every dimension. Between the implementation of the 340B ...
While more than 2,900 U.S. hospitals hold tax-exempt status as nonprofits, critics argue they have undergone a “mission drift ...
Michigan hospitals are systematically exploiting a program for low-income patients, according to a new report.
The 340B Drug Pricing Program was meant to help low-income patients, writes Rick Dowlearn, but it’s being used by hospitals ...
Healthcare policy changes may increase uncompensated care, stressing hospitals and the 340B program, crucial for subsidizing low-income patient care. The 340B rebate model, starting in 2026, could ...
An AHA blog examines new data released by the Health Resources and Services Administration on the growth of the 340B Drug ...
Recent data released by the Health Resources and Services Administration show that drug purchases made under the 340B Drug Pricing Program totaled $81.4 billion in 2024.
The AHA and several safety-net providers argue that an upcoming mandatory rebate pilot violates administrative law, imposes millions in costs, and threatens patient care in vulnerable communities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback